Category Specific RSS

pharmaceuticals

Karst backs Aussie small cap following hugely successful pharma strategy

Leading fund manager Karst Peak Capital has secured a significant interest in a little-known Aussie pharmaceuticals research company, following the…

5 years ago

New Anatara trial to tackle anxiety, stress and depression with diet supplement

Working in conjunction with the CSIRO, Anatara Lifesciences (ASX: ANR) has received ethics approval to apply their diet supplement 3FDC…

5 years ago

Quickfire FDA approval for Acrux’s testosterone sends share price soaring

Aussie pharmaceuticals company Acrux (ASX: ACR) is quickly making inroads through the lucrative American healthcare system with regulatory approval granted…

5 years ago

CLINUVEL to trial new drug addressing irreversible brain damage from by stroke

Leading pharmaceuticals company CLINUVEL (ASX: CUV) is set to commence human trials using the drug afamelanotide to dissolve or remove…

5 years ago

With trade stalling in China, Eagle Health turns to Africa with new continental distributor

As fears over the coronavirus outbreak continue to spread, health and nutritional product manufacturer Eagle Health (ASX: EHH) is set…

6 years ago

THC Global secures permit to commence medicinal cannabis manufacturing in Queensland

Australian cannabis pharmaceuticals company THC Global (ASX: THC) is one major step closer to their ‘Farm to Pharma’ strategy, having…

6 years ago